{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:43:03Z","timestamp":1782276183620,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01888-2","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:03:05Z","timestamp":1659528185000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of arterial stiffness and serum endocan levels in patients with primary aldosteronism with new-onset hypertension and long-term hypertension"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Can","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kocaba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. \u00c7.","family":"Burgucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Yarar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Karadeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karak\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. H.","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kulaks\u0131zo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"1888_CR1","unstructured":"Young, Jr, WF, Kaplan NM,  Rose BD (2014)  Approach to the patient with hypertension and hypokalemia. UpToDate Feb 2014"},{"issue":"13","key":"1888_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1055\/s-0035-1565124","volume":"47","author":"A Prejbisz","year":"2015","unstructured":"Prejbisz A, Warcho\u0142-Celi\u0144ska E, Lenders JW, Januszewicz A (2015) Cardiovascular risk in primary hyperaldosteronism. Horm Metab Res 47(13):973\u2013980","journal-title":"Horm Metab Res"},{"key":"1888_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry. J Clin Endocrinol Metab 94:1125\u20131130","journal-title":"J Clin Endocrinol Metab"},{"key":"1888_CR4","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M et al (2013) ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159\u20132219. https:\/\/doi.org\/10.1093\/eurheartj\/eht151","journal-title":"Eur Heart J"},{"key":"1888_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","volume":"121","author":"GF Mitchell","year":"2010","unstructured":"Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al (2010) Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121:505\u2013511. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.886655","journal-title":"Circulation"},{"key":"1888_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318\u20131327. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.061","journal-title":"J Am Coll Cardiol"},{"key":"1888_CR7","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.jacc.2014.09.060","volume":"64","author":"A Redheuil","year":"2014","unstructured":"Redheuil A, Wu CO, Kachenoura N, Ohyama Y, Yan RT, Bertoni AG et al (2014) Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study. J Am Coll Cardiol 64:2619\u20132629. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.060","journal-title":"J Am Coll Cardiol"},{"key":"1888_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1161\/01.HYP.33.5.1111","volume":"33","author":"J Blacher","year":"1999","unstructured":"Blacher J, Asmar R, Djane S, London GM, Safar ME (1999) Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:1111\u20131117","journal-title":"Hypertension"},{"key":"1888_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0253-7613.144891","volume":"46","author":"A Kali","year":"2014","unstructured":"Kali A, Shetty KSR (2014) Endocan: a novel circulating proteoglycan. Indian J Pharmacol 46:579\u2013583. https:\/\/doi.org\/10.4103\/0253-7613.144891","journal-title":"Indian J Pharmacol"},{"key":"1888_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jcp.24485","volume":"229","author":"W Lee","year":"2014","unstructured":"Lee W, Ku S-K, Kim S-W, Bae J-S (2014) Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 229:620\u2013630. https:\/\/doi.org\/10.1002\/jcp.24485","journal-title":"J Cell Physiol"},{"key":"1888_CR11","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","volume":"167","author":"D B\u00e9chard","year":"2001","unstructured":"B\u00e9chard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M et al (2001) Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a\/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 167:3099\u20133106","journal-title":"J Immunol"},{"key":"1888_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/0003319715625827","volume":"67","author":"T Cimen","year":"2016","unstructured":"Cimen T, Efe TH, Akyel A et al (2016) Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina. Angiology 67:846\u2013853","journal-title":"Angiology"},{"key":"1888_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0003319714548870","volume":"66","author":"M Kose","year":"2015","unstructured":"Kose M, Emet S, Akpinar TS et al (2015) Serum endocan level and the severity of coronary artery disease: a pilot study. Angiology 66:727\u2013731","journal-title":"Angiology"},{"issue":"1","key":"1888_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-2006-924973","volume":"38","author":"J Janke","year":"2006","unstructured":"Janke J, Engeli S, Gorzelniak K, Feldpausch M, Heintze U, B\u00f6hnke J, Wellner M, Herse F, Lassalle P, Luft FC, Sharma AM (2006) Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Horm Metab Res 38(1):28\u201333","journal-title":"Horm Metab Res"},{"issue":"5","key":"1888_CR15","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.5114\/amsad.2020.103031","volume":"26","author":"B Boyuk","year":"2020","unstructured":"Boyuk B, Cetin SI, Erman H, Sevinc S, Bulut U, Guzel S (2020) Evaluation of serum endocan levels in relation to epicardial fat tissue thickness in metabolic syndrome patients. Arch Med Sci Atheroscler Dis 26(5):e290\u2013e296","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"5","key":"1888_CR16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JM Funder","year":"2016","unstructured":"Funder JM, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"1888_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Sechi LA, Giacchetti G et al (2008) Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19:88\u201390","journal-title":"Trends Endocrinol Metab"},{"key":"1888_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","volume":"350","author":"A McCurley","year":"2012","unstructured":"McCurley A, Jaffe IZ (2012) Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol 350:256\u2013265","journal-title":"Mol Cell Endocrinol"},{"key":"1888_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.HYP.28.5.785","volume":"28","author":"D Rizzoni","year":"1996","unstructured":"Rizzoni D, Porteri E, Castellano M et al (1996) Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 28:785\u2013790","journal-title":"Hypertension"},{"key":"1888_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0895-7061(02)03199-0","volume":"16","author":"BM Schmidt","year":"2003","unstructured":"Schmidt BM, Schmieder RE (2003) Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens 16:80\u201386","journal-title":"Am J Hypertens"},{"key":"1888_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"1888_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41\u201350","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1888_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.33549\/physiolres.932344","volume":"61","author":"J Rosa","year":"2012","unstructured":"Rosa J, Soml\u00f3ov\u00e1 Z, Petr\u00e1k O, Strauch B, Indra T, Senitko M, Zelinka T, Holaj R, Widimsk\u00fd J Jr (2012) Peripheral arterial stiffness in primary aldosteronism. Physiol Res 61(5):461\u2013468","journal-title":"Physiol Res"},{"issue":"9","key":"1888_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.amjhyper.2006.02.002","volume":"19","author":"B Strauch","year":"2006","unstructured":"Strauch B, Petr\u00e1k O, Wichterle D, Zelinka T, Holaj R, Widimsk\u00fd J Jr (2006) Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 19(9):909\u2013914","journal-title":"Am J Hypertens"},{"issue":"1","key":"1888_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/joim.13115","volume":"289","author":"MK Choudhary","year":"2021","unstructured":"Choudhary MK, V\u00e4rri E, Matikainen N, Koskela J, Tikkakoski AJ, K\u00e4h\u00f6nen M, Niemel\u00e4 O, Mustonen J, Nevalainen PI, P\u00f6rsti I (2021) Primary aldosteronism: higher volume load, cardiac output and arterial stiffness than in essential hypertension. J Intern Med 289(1):29\u201341","journal-title":"J Intern Med"},{"issue":"10","key":"1888_CR26","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ajh.2008.243","volume":"21","author":"B Strauch","year":"2008","unstructured":"Strauch B, Petr\u00e1k O, Zelinka T, Wichterle D, Holaj R, Kasalick\u00fd M, Safar\u00edk L, Rosa J, Widimsk\u00fd J Jr (2008) Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 21(10):1086\u20131092","journal-title":"Am J Hypertens"},{"issue":"1","key":"1888_CR27","doi-asserted-by":"publisher","first-page":"147032032199949","DOI":"10.1177\/1470320321999491","volume":"22","author":"M Sang","year":"2021","unstructured":"Sang M, Fu Y, Wei C, Yang J, Qiu X, Ma J, Qin C, Wu F, Zhou X, Yang T, Sun M (2021) Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension. J Renin Angiotensin Aldosterone Syst 22(1):1470320321999491","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01888-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T15:25:35Z","timestamp":1673623535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01888-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1888"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01888-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Necmettin Erbakan University Meram School of Medicine Ethics Committee approved the study with the approval no 2021\/3080 and the date 04.06.2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients and healthy volunteers were informed in detail about the study, and the subjects were enrolled in the study after signing the informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in our study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}